PLASMINOGEN-ACTIVATOR INHIBITOR-2 EXPRESSION IN INFLAMED APPENDIX

被引:11
|
作者
WHAWELL, SA
THOMPSON, EM
FLEMING, KA
THOMPSON, JN
机构
[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT SURG,LONDON,ENGLAND
[2] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HISTOPATHOL,LONDON W12 0HS,ENGLAND
[3] UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT PATHOL & BACTERIOL,OXFORD OX3 9DU,ENGLAND
基金
英国惠康基金;
关键词
PLASMINOGEN ACTIVATOR INHIBITOR; APPENDICITIS; IN SITU HYBRIDIZATION;
D O I
10.1111/j.1365-2559.1995.tb00295.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Plasminogen activator inhibitors are thought to be responsible for the abolition of fibrinolytic activity in inflamed peritoneum, This reduction in the fibrin clearing capacity of the peritoneum promotes the formation of intra-abdominal adhesions, High concentrations of plasminogen activator inhibitor-2 (PAI-2) have been previously found in inflamed peritoneal tissue using immunoassays, but it is undetectable in normal peritoneum, The aim of this study was to localize plasminogen activator inhibitor-2 production in tissue by in situ mRNA hybridisation. Sections of normal and inflamed human appendix were hybridised with a digoxigenin labelled cDNA probe, In normal appendix staining was confined to macrophages in the mucosa. Macrophage staining was also seen in inflamed tissue but with a wider distribution throughout the appendix wall. PAI-2 was also localized to mesothelial cells of inflamed but not normal appendix, Cell identities were confirmed using immunohistochemistry directed against cell specific markers, Staining was absent from control slides incubated with plasmid DNA or PAI-2 probe following ribonuclease digestion, The identification of the cells expressing the PAI-2 gene in peritoneum increases our understanding of the pathophysiological process leading to fibrin deposition within the abdomen during peritonitis.
引用
收藏
页码:75 / 78
页数:4
相关论文
共 50 条
  • [1] EXPRESSION OF HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN THE BACULOVIRUS EXPRESSION SYSTEM
    PEI, Y
    ZHOU, AW
    CAO, XR
    XU, XX
    [J]. BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, 1995, 35 (05): : 923 - 928
  • [2] PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN VARIOUS DISEASE STATES
    KRUITHOF, EKO
    GUDINCHET, A
    BACHMANN, F
    [J]. THROMBOSIS AND HAEMOSTASIS, 1988, 59 (01) : 7 - 12
  • [3] PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN PATIENTS WITH MONOCYTIC LEUKEMIA
    SCHERRER, A
    KRUITHOF, EKO
    GROB, JP
    [J]. LEUKEMIA, 1991, 5 (06) : 479 - 486
  • [4] PLASMINOGEN-ACTIVATOR INHIBITOR-2 - BIOCHEMICAL AND CLINICAL ASPECTS
    KRUITHOF, EKO
    SCHLEUNING, WD
    BACHMANN, F
    [J]. THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 534 - 534
  • [5] BIOLOGY AND FACULTATIVE SECRETION OF PLASMINOGEN-ACTIVATOR INHIBITOR-2
    BELIN, D
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 70 (01) : 144 - 147
  • [6] INDEPENDENT REGULATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-2 AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN HUMAN SYNOVIAL FIBROBLASTS
    HAMILTON, JA
    CHEUNG, D
    FILONZI, EL
    PICCOLI, DS
    WOJTA, J
    GALLICHIO, M
    MCGRATH, K
    LAST, K
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (12): : 1526 - 1534
  • [7] INDEPENDENT GENE-EXPRESSION OF UROKINASE-PLASMINOGEN ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN MONONUCLEAR PHAGOCYTES
    GYETKO, MR
    WEBB, AC
    SITRIN, RG
    [J]. CLINICAL RESEARCH, 1988, 36 (03): : A505 - A505
  • [8] CALCITRIOL-MEDIATED MODULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-2
    KOLE, KL
    GYETKO, MR
    SIMPSON, RU
    SITRIN, RG
    [J]. BIOCHEMICAL PHARMACOLOGY, 1991, 41 (04) : 585 - 591
  • [9] COMPARISON OF PRIMARY STRUCTURES OF INHIBITOR-1 AND INHIBITOR-2 OF PLASMINOGEN-ACTIVATOR
    KRUITHOF, EKO
    SCHLEUNING, WD
    BACHMANN, F
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, : 49 - 49
  • [10] ISOLATION AND ANALYSIS OF THE PROMOTER REGION OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-2 GENE
    KRUITHOF, EKO
    COUSIN, E
    [J]. THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 88 - 88